Globally, an estimated 20 million people developed cancer in 2022 a figure expected to increase 77% to 35 million by 2050, with poorer countries bearing the brunt, according to new data.
Recent changes to lung cancer screening will expand the eligible population, but experts cautioned that long-standing barriers to screening may mean that screening rates remain low.